Battlefield Biotech: The Rising Competition Between China and the U.S.
Mar 26, 2018 | 09:00 GMT
(MARIO TAMA/Getty Images)
- Biotechnologies, especially gene-editing techniques, are evolving at a rapid pace. China's domestic sector is catching up with the West most rapidly in the area of health care.
- China's compulsion to overcome environmental and demographic constraints will ensure it continues to give priority to developing its domestic biotechnology sector.
- The West, in turn, will watch for shifts in Chinese policy that would allow for foreign participation in the country, while moving to protect its intellectual property there.